EASTMAN CHEMICAL CO (EMN): 10-Q filed July 31, 2026

AI analysis of the 10-Q that EASTMAN CHEMICAL CO filed with the U.S. SEC on July 31, 2026, grounded in the primary-source EDGAR filing.

• Chemical Intermediates Segment Volatility: Dramatic $88M swing from -$30M EBIT loss (Q2 2025) to +$58M recovery (Q2 2026) signals extreme cyclicality or potential one-time charges, creating material earnings unpredictability that warrants investor scrutiny

• Masked Deterioration in Portfolio: While consolidated Adjusted EBIT grew 9% YoY to $354M, underlying segment-level weakness in Advanced Materials and Fibers offsets Chemical Intermediates gains, indicating uneven business health

• Persistent Structural Cost Challenges: Corporate costs remain elevated at -$34M despite $16M improvement YoY, suggesting operational challenges persist despite headline gains and limiting upside potential

• Cautious Management Outlook: Neutral-to-slightly-cautious sentiment reflects management uncertainty around sustainability of improvements; investors should expect continued earnings volatility and monitor segment-level trends closely

Filing analysis — key questions

Answers are generated from this SEC filing and StockHuntr's analysis. Not investment advice.

What does EASTMAN CHEMICAL CO (EMN)'s 10-Q filed July 31, 2026 say?

Q2 2026 Quarterly Financial Results: Filing reports second quarter 2026 performance for Eastman Chemical Company across four operating segments—Advanced Materials, Additives & Functional Products, Chemical Intermediates, and Fibers—with total operating segment sales of $2,510 million and adjusted EBIT of $354 million Segment Performance Breakdown: Advanced Materials generated $817 million in…

Is EMN's 10-Q bullish or bearish?

Our analysis rates this filing CAUTIOUS. The elevated concern level (5.8/10) reflects a mixed but cautious picture. While consolidated Adjusted EBIT grew 9% YoY and the company maintains solid absolute profitability, multiple concerning signals warrant investor caution. The extreme volatility in…

How concerning is EMN's latest 10-Q?

Concern level: ELEVATED (5.8/10). Key factors: Chemical Intermediates segment shows extreme volatility with $88M swing in EBIT (-$30M Q2 2025 to +$58M Q2 2026), creating earnings unpredictability and suggesting either significant one-time charges or highly cyclical market exposure; Three new risks identified with average severity of 5/10: profitability decline in Chemical Intermediates (severity…

What are the main risks flagged in EMN's 10-Q?

Notable risk changes: Chemical Intermediates segment profitability collapsed in Q2 2025 (-$30M EBIT) but recovered sharply in Q2 2026 (+$58M), indicating extreme cyclicality or one-time charges that create earnings unpredictability; Total segment Adjusted EBIT increased 9% YoY ($354M vs $325M) but this masks significant segment-level volatility and deterioration in Advanced Materials and Fibers segments;…

Did EMN beat or miss expectations in this filing?

Not disclosed in provided excerpt.

What is the 30-day stock outlook for EMN after this filing?

The model predicts EMN will underperform the S&P 500 by about 0.0% over 30 days. This is model analysis for research, not investment advice.

About this analysis

Primary source:
View this 10-Q on SEC EDGAR
Additional data:
Yahoo Finance (market data)
Method:
StockHuntr analyzes filings with AI — see our methodology.
Analysis as of:
July 31, 2026
Published by:
StockHuntr

For research and education only. Nothing here is investment advice.

📄

Fetching Filing from SEC

Downloading filing HTML from SEC.gov...

15% Complete
1
Fetch filing from SEC
2
Parse document sections
3
Fetch prior filing
4
Analyze risk factors
5
Analyze management sentiment
6
Extract financial metrics
7
Compare to analyst consensus
8
Run ML prediction model
9
Finalize analysis

Note: Analysis typically takes 30-60 seconds. We're fetching real SEC filing data and running AI analysis on the actual content.